BENEFIT-RISK ASSESSMENT OF COVID-19 VACCINE, MRNA (MRNA-1273) FOR MALES AGE 18-64 YEARS https://www.medrxiv.org/content/10.1101/2022.12.02.22283050
BENEFIT-RISK ASSESSMENT OF COVID-19 VACCINE, MRNA (MRNA-1273) FOR MALES AGE 18-64 YEARS https://www.medrxiv.org/content/10.1101/2022.12.02.22283050